贝伐单抗植入术治疗复杂青光眼年轻患者的经验。

Experience with the baerveldt implant in young patients with complicated glaucomas.

机构信息

Doheny Eye Institute and the Department of Ophthalmology, University of Southern California School of Medicine, Los Angeles, California. U.S.A.

出版信息

J Glaucoma. 1995 Apr;4(2):91-7.

PMID:19920652

Abstract

PURPOSE

Previous studies have suggested that glaucoma shunt implantation may be useful in the management of glaucoma in young patients in whom goniotomy and/or trabeculotomy have failed or are inappropriate. Herein, we describe our initial experience with Baerveldt implantation in young patients with complicated glaucomas.

METHODS

Charts of all patients with glaucoma who were under 21 years of age, and who underwent Baerveldt implantation between March 1, 1991 and March 1, 1993 with at least a 6-month follow-up (30 eyes of 30 patients) were reviewed retrospectively.

RESULTS

The patients' ages ranged from 2 months to 20 years (mean, 6.6 +/- 6.4 years) with follow-up of 6-25 months (mean, 15.0 +/- 6.3 months). Intraocular pressure (IOP) was reduced from a preoperative range of 17-78 mm Hg (mean, 35.5 +/- 13.1 mm Hg) to a range of 6-22 mm Hg (mean, 13.5 +/- 4.2 mm Hg) postoperatively. Six- and 12-month life-table success rates (6 +/- IOP +/- 21 without additional glaucoma surgery or devastating complication) were 93% and 86%, respectively.

CONCLUSION

Baerveldt implantation is a useful approach to the treatment of glaucoma in young patients with complicated glaucomas.

摘要

目的

先前的研究表明，对于那些小梁切开术和/或小梁切除术失败或不适用的年轻青光眼患者，青光眼引流管植入可能是一种有用的治疗方法。在此，我们描述了我们在年轻复杂青光眼患者中使用 Baerveldt 植入物的初步经验。

方法

回顾性分析了 1991 年 3 月 1 日至 1993 年 3 月 1 日期间接受 Baerveldt 植入术且至少随访 6 个月（30 例患者 30 只眼）的年龄小于 21 岁的青光眼患者的图表。

结果

患者年龄为 2 个月至 20 岁（平均 6.6 +/- 6.4 岁），随访时间为 6-25 个月（平均 15.0 +/- 6.3 个月）。眼压（IOP）从术前 17-78mmHg（平均 35.5 +/- 13.1mmHg）降至术后 6-22mmHg（平均 13.5 +/- 4.2mmHg）。6 个月和 12 个月的生存表成功率（6 +/- IOP +/- 21 无其他青光眼手术或严重并发症）分别为 93%和 86%。